|
CBX2 expression profile based on
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| ER negative-vs-ER positive | 2.46395673525813E-137
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| HER2 Negative-vs-HER2 Positive | 8.04057472634481E-38
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Insitu-vs-Invasive | 8.269896E-01 |
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Non-TNBC tumors-vs-TNBC tumors | <1E-12 |
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| PR Negative-vs-PR Positive | 9.0373516822983E-132
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Ki67 Low-vs-Ki67 High | 4.12147544076701E-151
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
| Comparison | Statistical significance |
| Lymph Node Negative-vs-Lymph Node Positive | 5.2857441010935E-06
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Grade 1-vs-Grade 2 |
1.17751940503137E-17 |
| Grade 1-vs-Grade 3 |
3.76640306506967E-233 |
| Grade 2-vs-Grade 3 |
2.46608237052644E-200 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| 21-40yrs-vs-41-60yrs |
4.97522778903225E-07 |
| 21-40yrs-vs-61-80yrs |
1.98716202604049E-13 |
| 21-40yrs-vs-81-100yrs |
1.28558787233935E-09 |
| 41-60yrs-vs-61-80yrs |
7.40254593098194E-09 |
| 41-60yrs-vs-81-100yrs |
1.401184E-02 |
| 61-80yrs-vs-81-100yrs |
4.693157E-02 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| T1-vs-T2 |
8.83197937959306E-23 |
| T1-vs-T3 |
2.790169E-02 |
| T1-vs-T4 |
7.177169E-04 |
| T1-vs-Tis |
3.704874E-01 |
| T2-vs-T3 |
1.470378E-01 |
| T2-vs-T4 |
4.820529E-02 |
| T2-vs-Tis |
1.188764E-02 |
| T3-vs-T4 |
1.587338E-02 |
| T3-vs-Tis |
3.777846E-01 |
| T4-vs-Tis |
4.446674E-03 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal like-vs-LumA |
6.88580375380197E-25 |
| Normal like-vs-LumB |
4.51718609351384E-15 |
| Normal like-vs-HER2 enriched |
3.07832510412158E-91 |
| Normal like-vs-Basal like |
6.66710940672256E-122 |
| LumA-vs-LumB |
2.02626490363006E-62 |
| LumA-vs-HER2 enriched |
1.34335370847381E-112 |
| LumA-vs-Basal like |
2.36487104865067E-139 |
| LumB-vs-HER2 enriched |
4.87522844305424E-67 |
| LumB-vs-Basal like |
6.1684576288895E-100 |
| HER2 enriched-vs-Basal like |
3.94178235971265E-07 |
|
|
Staaf J, Häkkinen J, Hegardt C, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94. Published 2022 Aug 16. doi:10.1038/s41523-022-00465-3
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Ductal-vs-Lobular |
9.96413954259084E-151 |
| Ductal-vs-Ductal_Lobular |
8.35848816620931E-14 |
| Ductal-vs-Ductal_Other |
7.244499E-02 |
| Ductal-vs-Other |
5.222204E-02 |
| Lobular-vs-Ductal_Lobular |
1.223962E-01 |
| Lobular-vs-Ductal_Other |
7.819266E-03 |
| Lobular-vs-Other |
5.66629389644687E-14 |
| Ductal_Lobular-vs-Ductal_Other |
6.908236E-02 |
| Ductal_Lobular-vs-Other |
9.37333674924605E-06 |
| Ductal_Other-vs-Other |
4.144390E-01 |
|
|
